In Italy, the Council of State says YES to hydroxychloroquine as a treatment for Covid-19

Publié le 11 décembre 2020 - 15:55
Cachets d'hydroxychloroquine,sur le comptoir d'une pharmacie, à Provo, dans l'Utah, le 20 mai 2020
© GEORGE FREY / AFP/Archives
In Italy, the Council of State says YES to hydroxychloroquine as a treatment for Covid-19
© GEORGE FREY / AFP/Archives

Through order 7097/2020 issued today, the Italian Council of State says yes to the use of hydroxychloroquine as a treatment for Covid-19, provided it is prescribed by a doctor. The order also confirms the decision of the pharmaceutical agency to exclude the drug from reimbursement.

Doing so, the Council of State accepts, as a precautionary measure, the appeal of a group of general practitioners and suspends the recommendation of the Aifa (Italian Medicine Agency) of 22 July 2020 which previously prohibited the prescription of hydroxychloroquine outside of the government health agencies authorization as a treatment against Covid-19. (i.e. for use not included in the drug's instructions, aka "off-label").

The order states:

"The continuing uncertainty about the therapeutic efficacy of hydroxychloroquine, declared by Aifa to justify its continued evaluation, evaluation in randomized clinical trials -  is not a sufficient legal reason to justify the unreasonable suspension of its use on the Italian territory by treating physicians."

The Council of State seems to have heard the message of treating doctors and specialists when declaring:

'The choice of whether or not to use the drug, in a situation of doubt and opposition in the scientific community, on the basis of non-unequivocal clinical data, on its effectiveness at the initial stage of the disease only, must therefore be handed over to the decision-making autonomy and responsibility of the individual physician in science and conscience and with the obvious informed consent of each patient, without prejudice to the constant and attentive supervision of the doctor who prescribe it.'

This decision, which is a first in Europe, comes after different joint initiatives by Italian doctors, especially a petition mentioned in a previous article, following an AIFA's first move on the 15th of November. On the 15th of October, FranceSoir wrote that a group of general practitioners had stated: "We will use hydroxychloroquine as a treatment for early-stage Covid-19".

In France, a tweet from Professor Didier Raoult's lawyer stated:

"And here is Didier Raoult's release. Legal endgame"

With ongoing legal actions concerning the use of hydroxychloroquine as a Covid-19 early-stage treatment in France, this decision in Italy should help to move the lines. It comes after a succession of hearings of emeritus physicians on early-stage treatments, such as Professor Peter McCullough, at the American Senate on the initiative of Senator Johnson interviewed and Prof. Harvey Risch. Yesterday, in another debriefing, Dr. Pierre Kory declared about ivermectin, another early-stage treatment: "We have a treatment that works, we must use it and the health agencies should allow it as soon as possible."


Debriefing Dr Pierre Koury
Pierre Kory : "Ivermectine : nous avons un traitement qui marche !"
Un Debriefing proposé en partenariat avec recevons aujourd'hui le Dr Pierre Kory, médecin urgentiste américain qui a témoigné au Sénat de son pays lor...
10 décembre 2020 - 16:43
Debriefing Johnson Risch
Sénateur Ron Johnson et Dr Harvey Risch : "Ils ne reconnaîtront jamais leurs torts !"
Un Debriefing américain avec le sénateur du Wisconsin Ron Johnson, et l'éminent épidémiologiste de Yale, le Dr Harvey Risch, pour répondre aux questions de France Soir...
28 novembre 2020 - 13:29
Debriefing Dr McCullough
Dr McCullough : "les historiens jugeront très sévèrement" les autorités sanitaires
Debriefing en partenariat avec, du docteur Peter McCullough, spécialiste en médecine interne et maladies cardiovasculaires, et "vice chief of medicine" à l...
02 décembre 2020 - 18:22

L'article vous a plu ? Il a mobilisé notre rédaction qui ne vit que de vos dons.
L'information a un coût, d'autant plus que la concurrence des rédactions subventionnées impose un surcroît de rigueur et de professionnalisme.

Avec votre soutien, France-Soir continuera à proposer ses articles gratuitement  car nous pensons que tout le monde doit avoir accès à une information libre et indépendante pour se forger sa propre opinion.

Vous êtes la condition sine qua non à notre existence, soutenez-nous pour que France-Soir demeure le média français qui fait s’exprimer les plus légitimes.

Si vous le pouvez, soutenez-nous mensuellement, à partir de seulement 1€. Votre impact en faveur d’une presse libre n’en sera que plus fort. Merci.

Je fais un don à France-Soir

Dessin de la semaine

Soutenez l'indépendance de FS

Faites un don

Nous n'avons pas pu confirmer votre inscription.
Votre inscription à la Newsletter hebdomadaire de France-Soir est confirmée.

La newsletter France-Soir

En vous inscrivant, vous autorisez France-Soir à vous contacter par e-mail.